VRd | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,516 results for “VRd”

Trials

View all 985 →

Active, not recruiting

A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma

40 participants · First posted May 16, 2023

Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients

50 participants · First posted Jul 19, 2019

Not yet recruiting

Isa-VRD in TIE HRMM

117 participants · First posted Jan 12, 2026

Drugs

View all 347 →

VRDN-003

VRDN-004

VRDN-006

Organizations

Viridian Metals Inc

United States

VR1 Corporation

United States

MALLINCKRODT ARD INC

United States

News

View all 177 →

Isatuximab Combinations Show Promise in Newly Diagnosed Multiple Myeloma

Daratumumab-Based Regimens Deepen Responses and Improve MRD Negativity in Multiple Myeloma

CEPHEUS Trial Supports Quadruplet Therapy with Daratumumab as New Standard in Multiple Myeloma

Page 1 of 152